Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study

Previous research has been highly suggestive that patients of African ancestry are less responsive to beta-blockers and angiotensin converting enzyme inhibitors. However, clinical practice within Ethiopia has continued to recommend all drugs for treatment of hypertension despite the lack of evidenti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2018-09, Vol.13 (9), p.e0203166
Hauptverfasser:	Mengesha, Hayelom Gebrekirstos, Welegerima, Abraha Hailu, Hadgu, Abera, Temesgen, Haftom, Otieno, Mala George, Tsegay, Kiflom, Fisseha, Tedros, Getachew, Samuel, Merha, Zekarias, Tewodros, Helen, Dabessa, Jiksa, Gebreegzabher, Berhane, Petrucka, Pammla
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Analysis Angiotensin Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Antihypertensive Agents - therapeutic use Antihypertensives Black People Blood Blood pressure Blood Pressure - drug effects Calcium Channel Blockers - therapeutic use Care and treatment Clinical medicine Clinical trials Comparative analysis Comparative studies Covariance Diuretics Diuretics - therapeutic use Dosage and administration Drug dosages Drugs Enalapril - therapeutic use Enzyme inhibitors Enzymes Ethiopia Evidence-based practice Female Health care Health Services Hospitals Humans Hydrochlorothiazide Hydrochlorothiazide - therapeutic use Hypertension Hypertension - drug therapy Hypertension - physiopathology Internal medicine Male Medicine Medicine and Health Sciences Middle Aged Motivation Nifedipine Nifedipine - therapeutic use Patients People and Places Peptidyl-dipeptidase A Pharmacy Pilot Projects Practice guidelines (Medicine) Prescription drugs Prospective Studies Randomization Reduction Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!